The following information is intended for healthcare professionals only. Always read the label and follow the directions for use.
The following information is intended for healthcare professionals only. Always read the label and follow the directions for use.
Different Pack Sizes
To fit different needs
Needle Length
Optimising effectiveness
'There is no medical reason to recommend pen needles longer than 5mm for children and adults.'¹
Skin thickness for adults ranges from 2mm - 2.5mm across common injection sites, regardless of BMI. Long needles increase the risk of injecting into the muscle which can cause pain and improper absorbtion of medication.2,3
According to the Australian Diabetes Educators Association (ADEA) Clinical Guiding Principles for Subcutaneous Injection Technique, therapy should commence with short (4mm - 5mm) pen needle lengths.¹ Short needle lengths help reduce injection discomfort whilst ensuring effective delivery.¹
1
Why short 4mm or 5mm pen needles?
- Ensures medication is delivered into the subcutaneous layer.¹
- To substantially reduce the risk of intramuscular injection compared to 6mm and 8mm pen needle lengths.3, †
- Suitable for all, including children, adults and obese patients.¹
Image source: Australian Diabetes Educators Association (ADEA) Clinical Guiding Principles for Subcutaneous Injection Technique 2019
The BD Ultra-FineTM 5mm Pen Needles in a 7-pack offers an alternative pack size for those injecting once weekly, such as with Mounjaro KwikPen.* Our 100-pack remains the option for those with more frequent injection needs, such as insulin users.
Needle Quantity
Different pack sizes to fit different needs.
2
Compatible with widely used pen devices, including Mounjaro KwikPen 4,*
100 Packs
People on weekly GLP-1 (for weight management) who are not diabetic, typically use 4 Needles per month. Therefore 7-packs represent a convenient choice.
An alternative pack size for those injecting once weekly, such as with Mounjaro KwikPen.*
Consider convenient 7-packs for people on weekly GLP-1 (for weight management) who are not diabetic, as they typically only use 4 Needles per month.
Convenient dispensing solution
Bulk option available for daily injections
Efficient inventory management in pharmacy
7 Packs
With the BD Ultra-FineTM 5mm Pen Needles in a convenient 7-pack, this means two packs (14 pen needles) can last up to three months for patients on weekly injectable therapy such as Mounjaro KwikPen.*^
Note: Note: in this example, months 1 and 3 span 5 weeks^
People on weekly GLP-1 (for weight management) who are not diabetic, typically use 4 Needles per month. Therefore 7-packs represent a convenient choice.
Consider convenient 7-packs for people on weekly GLP-1 (for weight management) who are not diabetic, as they typically only use 4 Needles per month.
Ordering BD Ultra-FineTM 5mm Pen Needles
617768
796077
100 Pack
7 Pack
10008412
10035358
100 Pack
7 Pack
2431576
2737250
100 Pack
7 Pack
43389
87832
100 Pack
7 Pack
796077
7 Pack
10035358
7 Pack
2737250
7 Pack
87832
7 Pack
For Further Enquiries
Alternatively, complete the contact form below and we'll get back to you as soon as possible.
For Further Enquiries
For any further enquiries, we encourage you to reach out to the embecta team. We look forward to speaking to you.
To learn more about recommended injecting practice in Australia, download the Australian Diabetes Educators Association (ADEA) Clinical Guiding Principles for Subcutaneous Injection Technique
† IM risk was estimated based on 90 or 45 degree insertion. Skin surface to muscle depth was measured by ultrasound. No actual injections were performed.
* embecta’s use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between embecta and the owners of these trademarks
^ Example only, modelled based on Month 1 (August 2025) having 4 weeks, Month 2 (September 2025) having 5 weeks and Month 3 (October 2025) having 4 weeks. It is assumed one pen needle per week is used and that no pen needles are defective in the 7-pack.
^ Use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between embecta and the owners of these trademarks
References
- Australian Diabetes Educators Association (ADEA) Clinical Guiding Principles for Subcutaneous Injection Technique 2019
- Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255.
- Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530.
- Compatibility Confirmation for BD Pen Needles/149OTH-0004-20, 01 August 2024
^ Use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between embecta and the owners of these trademarks
embecta, formerly part of BD. BD is the manufacturer of the advertised products. embecta and the embecta logo are trademarks of Embecta Corp. BD and the BD logo are trademarks of Becton, Dickinson and Company. All other trademarks are the property of their respective owners. © 2024 Embecta Corp. All rights reserved. EMB-04971
